| Literature DB >> 23029598 |
Watcharapong Piyaphanee1, Chatporn Kittitrakul, Saranath Lawpoolsri, Philippe Gautret, Wataru Kashino, Waraluk Tangkanakul, Prangthip Charoenpong, Thitiya Ponam, Suda Sibunruang, Weerapong Phumratanaprapin, Terapong Tantawichien.
Abstract
BACKGROUND: Each year millions of travelers visit Southeast Asia where rabies is still prevalent. This study aimed to assess the risk of rabies exposure, i.e., by being bitten or licked by an animal, among travelers in Southeast Asia. The secondary objective was to assess their attitudes and practices related to rabies. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 23029598 PMCID: PMC3459869 DOI: 10.1371/journal.pntd.0001852
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Demographic and travel characteristics (n = 7,681).
| n | % | |
| Sex (n = 7,667) | ||
| Male | 4,771 | 62.2 |
| Female | 2,896 | 37.8 |
| Age (year) [median 32 y; range 17–90 y] (AVR = 35.68 yr) | ||
| 17–30 | 3,529 | 45.9 |
| 31–45 | 2,422 | 31.5 |
| 46–60 | 1,307 | 17.0 |
| ≥61 | 423 | 5.5 |
| Nationality (n = 7,675) | ||
| Western and Central European | 2,612 | 34.0 |
| East Asian | 2,462 | 32.1 |
| Oceania (Australian, New Zealander) | 676 | 8.8 |
| South Asian | 543 | 7.1 |
| North American | 442 | 5.8 |
| Middle East+Central Asian | 330 | 4.3 |
| Eastern European | 256 | 3.3 |
| Central and South American | 180 | 2.3 |
| African | 174 | 2.3 |
| Reason for travel (n = 7,650) | ||
| Tourism | 6,512 | 85.1 |
| Business | 450 | 5.9 |
| Visiting friends and relatives | 420 | 5.5 |
| Education or research | 110 | 1.4 |
| Other | 158 | 2.1 |
| Had sought any travel health information before leaving (n = 7,628) | ||
| Yes | 4,524 | 59.3 |
| No | 3104 | 40.7 |
| Source of travel heath information | ||
| Internet | 2,417 | 31.5 |
| General Practitioner | 1,892 | 24.7 |
| Travel Clinic | 1,809 | 23.6 |
| Friends and Relatives | 1,249 | 16.3 |
| Guidebooks/Magazines/News | 949 | 12.4 |
| Pharmacists | 875 | 13.4 |
| Other | 87 | 1.5 |
| Received rabies pre-exposure vaccine | ||
| Complete vaccination (3 shots) | 847 | 11.6 |
| Incomplete vaccination (1–2 shots) | 1,121 | 15.3 |
| No | 5,351 | 73.1 |
Travelers could have more than one source of travel health information.
Relation of Travel Clinic visit to Travelers' Knowledge about rabies.
| Pre-Travel Preparation | Overall | Visited Travel clinic |
| ||
| Yes (%)n = 1,809 | No (%)n = 5,860 | ||||
| 1 | Receive information about rabies | 41.90% | 56.00% | 37.50% | <0.001 |
| 2 | Receive complete pre-exposure rabies vaccine (3 doses) | 11.6% | 21.4% | 8.4% | <0.001 |
Statistical significance.
Factor that influence rabies pre-exposure vaccination.
| Total (n) | Received at least 1 dose of vaccine | Not received vaccine | Relative Risk (95% CI) | Adjusted RR | ||||
| n | % | n | % | (95% CI) | ||||
| Sex | ||||||||
| Male | 4771 | 1286 | 27 | 3485 | 73 | 1 | 1 | |
| Female | 2896 | 678 | 23 | 2218 | 77 | 0.83 (0.74–0.92) | 0.77 (0.69–0.86) | |
| Age group | ||||||||
| 17–30 | 3529 | 1006 | 29 | 2523 | 71 | 1 | 1 | |
| 31–45 | 2422 | 618 | 26 | 1804 | 74 | 0.86 (0.76–0.97) | 0.81 (0.72–0.92) | |
| 46–60 | 1307 | 287 | 22 | 1020 | 78 | 0.71 (0.61–0.82) | 0.72 (0.61–0.84) | |
| ≥61 | 423 | 57 | 13 | 366 | 87 | 0.39 (0.29–0.52) | 0.42 (0.31–0.56) | |
| Length of Stay (days) | ||||||||
| 0–5 | 2363 | 729 | 31 | 1634 | 69 | 1 | 1 | |
| 6–10 | 1306 | 292 | 22 | 1014 | 78 | 0.65 (0.55–0.75) | 0.64 (0.54–0.77) | |
| 11–15 | 1163 | 256 | 22 | 907 | 78 | 0.63 (0.54–0.74) | 0.66 (0.54–0.80) | |
| 16–20 | 678 | 139 | 21 | 539 | 79 | 0.58 (0.47–0.71) | 0.60 (0.47–0.76) | |
| >20 | 1917 | 484 | 25 | 1433 | 75 | 0.76 (0.66–0.87) | 0.80 (0.66–0.95) | |
| Nationality | ||||||||
| Western and Central European | 2612 | 659 | 25 | 1953 | 75 | 1 | 1 | |
| East Asian | 2462 | 706 | 29 | 1756 | 71 | 1.19 (1.05–1.35) | 0.98 (0.82–1.17) | |
| Oceania (AUS,NZ) | 676 | 99 | 15 | 577 | 85 | 0.51 (0.40–0.64) | 0.52 (0.41–0.66) | |
| South Asian | 543 | 186 | 34 | 357 | 66 | 1.54 (1.27–1.88) | 1.40 (1.12–1.75) | |
| North American | 442 | 63 | 14 | 379 | 86 | 0.49 (0.37–0.65) | 0.51 (0.37–0.68) | |
| Middle East+Central Asian | 330 | 93 | 28 | 237 | 72 | 1.16 (0.90–1.50) | 1.08 (0.82–1.40) | |
| Eastern European | 256 | 70 | 27 | 186 | 73 | 1.12 (0.83–1.48) | 1.15 (0.85–1.55) | |
| Central and South American | 180 | 51 | 28 | 129 | 72 | 1.17 (0.83–1.63) | 1.03 (0.72–1.46) | |
| African | 174 | 40 | 23 | 134 | 77 | 0.88 (0.61–1.26) | 0.82 (0.55–1.20) | |
| Reason for travel | ||||||||
| Tourism | 6512 | 1747 | 27 | 4765 | 73 | 1 | 1 | |
| Business | 450 | 80 | 18 | 370 | 82 | 0.59 (0.46–0.75) | 0.57 (0.43–0.73) | |
| Visiting friends and relatives | 420 | 63 | 15 | 357 | 85 | 0.48 (0.36–0.63) | 0.56 (0.42–0.74) | |
| Education or research | 110 | 28 | 25 | 82 | 75 | 0.93 (0.59–1.42) | 1.07 (0.67–1.64) | |
| Other | 158 | 41 | 26 | 117 | 74 | 0.96 (0.66–1.36) | 0.94 (0.63–1.36) | |
Mean prices of cell-cultured rabies vaccine (1 dose) for pre-exposure prophylaxis in selected countries.
| Country | Mean price for one intramuscular dose (USD) | Cost Index = mean price/gross domestic product per capita |
| India | 16 | 45 |
| Sri Lanka | 20 | 40 |
| Spain | 22 | 7 |
| Israel | 32 | 11 |
| Belgium | 33 | 9 |
| Russia | 35 | 18 |
| France | 38 | 11 |
| Republic of Ireland | 45 | 11 |
| Italy | 46 | 15 |
| South Africa | 48 | 46 |
| Norway | 49 | 9 |
| Republic of Korea | 55 | 19 |
| Brazil | 63 | 57 |
| Japan | 65 | 19 |
| United Kingdom | 70 | 19 |
| People's Republic of China | 70 | 93 |
| Switzerland | 73 | 16 |
| The Netherlands | 75 | 18 |
| Australia | 82 | 21 |
| Germany | 84 | 22 |
| New Zealand | 101 | 34 |
| Finland | 110 | 30 |
| Denmark | 114 | 30 |
| Sweden | 124 | 32 |
| Canada | 181 | 47 |
| United States of America | 200 | 42 |
Obtained from the World Development Indicators database, World Bank, accessed 1 February 2012.
Prices in India and Sri-Lanka are those in private international clinics. Rabies vaccine can be obtained also from government designed anti-rabies centers in India, but almost exclusively for post-exposure prophylaxis at an average price of 8 USD per intramuscular dose. Rabies vaccine in public sector in Sri-Lanka is free and used only for post-exposure prophylaxis.
Price in Spain is that in private clinic. The vaccine can be obtained for free in national centers.
Price in the People's Republic of China is an average of prices in public and private sectors (47 USD in government designed anti- rabies centers, usually for post-exposure prophylaxis, (cost index = 62) and 93 USD in private international clinics (cost index = 123). Price in the special administrative region of Hong-Kong (77 USD, cost index = 17) was not considered is the present study.
Animal exposure during this trip (n = 7,681).
| no. exposed | % | |
| Prevalence of Exposure (bitten+licked) | 219 | 2.85 |
| Number of travelers being bitten | 66 | 0.86 |
| Number of travelers being licked | 185 | 2.41 |
| Bitten or scratched by (n = 36) | ||
| Dog | 16 | 44.4 |
| Monkey | 14 | 38.9 |
| Cat | 3 | 8.3 |
| Other | 3 | 8.3 |
| Among travelers who are bitten (n = 35) | ||
| Clean the wound | 26 | 74.3 |
| Go to the hospital and get rabies vaccine | 13 | 37.1 |
| Do nothing | 3 | 8.6 |
Incidence of exposure (bitten and licked) per 100 travelers per month of stay.
Relative Risk of Animal Exposure.
| Total (n) | Exposed | Non-exposed | Relative Risk (95% CI) | Adjusted RR (95% CI) | |||
| n | % | n | % | ||||
| Sex | |||||||
| Male | 4,771 | 132 | 2.8 | 4,639 | 97.2 | 1 | 1 |
| Female | 2,896 | 87 | 3.0 | 2,809 | 97.0 | 1.09 (0.82–1.43) | 1.57 (0.78–1.39) |
| Age group | |||||||
| 17–30 | 3,529 | 118 | 3.3 | 3,411 | 96.7 | 1 | 1 |
| 31–45 | 2,422 | 58 | 2.4 | 2,364 | 97.6 | 0.71 (0.51–0.97) | 0.84 (0.60–1.16) |
| 46–60 | 1,307 | 32 | 2.4 | 1,275 | 97.6 | 0.73 (0.48–0.94) | 0.74 (0.48–1.10) |
| ≥61 | 423 | 11 | 2.6 | 412 | 97.4 | 0.77 (0.39–1.38) | 0.61 (0.30–1.13) |
| Length of Stay (days) | |||||||
| 0–5 | 2,363 | 31 | 1.3 | 2,332 | 98.7 | 1 | |
| 6–10 | 1,306 | 24 | 1.8 | 1,282 | 98.2 | 1.41 (0.82–2.40) | 2.39 (1.36–4.15) |
| 11–15 | 1,163 | 40 | 3.4 | 1,123 | 96.6 | 2.68 (1.67–4.33) | 5.43 (3.13–9.45 |
| 16–20 | 678 | 23 | 3.4 | 655 | 96.6 | 2.64 (1.51–4.54) | 5.18 (2.76–9.60) |
| >20 | 1,917 | 95 | 5.0 | 1,822 | 95.0 | 3.92 (2.64–6.00) | 7.78 (4.71–13.01) |
| Nationality | |||||||
| Western and Central European | 2,612 | 90 | 3.4 | 2,522 | 96.6 | 1 | 1 |
| East Asian | 2,462 | 69 | 2.8 | 2,393 | 97.2 | 0.81 (0.59–1.11) | 2.83 (1.87–4.26) |
| Oceania (Australian, New Zealander) | 676 | 31 | 4.6 | 645 | 95.4 | 1.35(0.87–2.02) | 1.74 (1.12–2.63) |
| South Asian | 543 | 2 | 0.4 | 541 | 99.6 | 0.10 (0.02–0.33) | 0.20 (0.03–0.66) |
| North American | 442 | 13 | 2.9 | 429 | 97.1 | 0.85 (0.45–1.48) | 1.05 (0.55–1.85) |
| Middle East+Central Asian | 330 | 4 | 1.2 | 326 | 98.8 | 0.34 (0.10–0.83) | 0.47 (0.14–1.14) |
| Eastern European | 256 | 5 | 2.0 | 251 | 98.0 | 0.56 (0.20–1.25) | 0.66 (0.23–1.51) |
| Central and South American | 180 | 3 | 1.7 | 177 | 98.3 | 0.47 (0.12–1.28) | 0.71 (0.17–1.95) |
| African | 174 | 2 | 1.1 | 172 | 98.9 | 0.33 (0.05–1.04) | 0.55 (0.09–1.79) |
| Reason for travel | |||||||
| Tourism | 6,512 | 181 | 2.8 | 6,331 | 97.2 | 1 | |
| Business | 450 | 13 | 2.9 | 437 | 97.1 | 1.04 (0.56–1.77) | |
| Visiting friends and relatives | 420 | 15 | 3.6 | 405 | 96.4 | 1.30 (0.73–2.14) | |
| Education or research | 110 | 4 | 3.6 | 106 | 96.4 | 1.32 (0.40–3.19) | |
| Other | 158 | 6 | 3.8 | 152 | 96.2 | 1.38 (0.54–2.90) | |
| Received vaccination against rabies | |||||||
| No | 5,713 | 177 | 3.1 | 5,536 | 96.9 | 1 | |
| Yes, only 1–2 shots | 1,121 | 20 | 1.8 | 1,101 | 98.2 | 0.57 (0.35–0.88) | |
| Yes, complete 3 shots | 847 | 22 | 2.6 | 825 | 97.4 | 0.83 (0.52–1.28) | |
| Knowledge score | |||||||
| 0–6 | 6,625 | 178 | 2.7 | 6,447 | 97.3 | 1 | 1 |
| 7–12 | 1,056 | 41 | 3.9 | 1,015 | 96.1 | 1.46 (1.02–2.05) | 1.10 (0.75–1.58) |
p-value<0.05.